Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I have had a reply back from the company but won’t be posting it here as too many have a go idiots on here. If any of the genuine holders want a copy then let me know and ideally need to have an account on twitter as that would be easiest way for me to forward email.
Personally I wouldn't agree but may not stop them from trying.
When companies take a step like that they have the backing of most shareholders and if not accepted BOD can make things very dificult going forward.
Anyway, let's see what is going on.
Marc and why would 75% of shareholders agree to de-listing?
TIA
Hi again.
Yes the questions start at around 1 hr 56 mins and there were 3 from analysts in the room and 1 online question was referenced by the CMO. 2hr 5mins is when the Investor Meets member says that there are quite a few questions that have come in today from investors and we can show you those and we can publish your response later.
Incidentally the mini spat between the CMO and the CSO wasn't a very good look and it did not appear to best please Mr Tovey.
https://www.youtube.com/watch?v=c7CQ6qPXvBI
I am invested in both Destiny and Ondine.
There is regular and positive communication from Ondine, although a commercial breakthrough has yet to be achieved. A similar approach to the provision of information by Destiny would be helpful.
Hi Noix again. I wasn’t invested at the time of the last presentation and watched it “retrospectively”. From memory, I think there were about four questions asked. If there were others that were not later addressed, then that is poor.
Ok, well that's not very good. Surely they can't pull the same stunt a 2nd time, but we'll see. Popcorn out on the 25th...
I stand to be corrected but they ran out of time for the Q and A the last time and we were told they would be released on Investor Meets.
Despite a request to Investor Meets, which was ignored, I'm not aware that they have ever been published.
I, for one, will be watching with great interest the Investor Meet Company presentation on the 25th, especially the Q&A. I guess it won't be a comfortable one. Will be looking out for commentary on cash reserves, burn rate, funding and the AIM market.
Morning to you 2.
Good point, given the savage drop, I completely forgot it's flagged as a results presentation.
Morning Noix, it was the same with last year’s results - the Investor Meet presentation was with both the CEO & CFO.
Yes, I must admit it does look on the cards, particularly so when other bio techs are doing likewise with e- therapeutics the latest.
Possibly a Nasdaq listing to follow, but it's telling to my mind that the presentation on Investor Meets is by the CEO and the CFO.
Will follow the step of others lately.
ETX, C4DX, BYOT
And with an American CEO..
Step up to the plate CT &/or Sir Nigel and explain the recent SP sharp falls.
This will de-list unfortunately.
Company happy with the outcome so far.
New CEO had it all planned.
Https://ondinebio.com/solutions/steriwave-healthcare/
Their shares are currently Cheap as Chips
imho - dyor
Reserved,
Accepted the Eddison article gives them very similar rates of efficacy. I was simply referring to an article linked in the post earlier, in fairness it does say at 'least' 50% so may be old.... the quote is made at 2.19 min's in..........
https://ondinebio.com/solutions/steriwave-healthcare/
The drop today, after recent declines , is concerning but I still bought today, Let's see what happens on the 25th
The Price/book (mrq) was 2.12 which was on the high side .
Not sure the fundamentals I posted from this site on 23rd March below mean much.
Top of the table 22% fall today to all time low of 20.3p.
27th July 2020 last all time low at 31p
So much for Hardman & co picks.
Neon Life shouldn’t revolve around looking for the hardest hit companies of the day then writing rubbish about them, get a life you loser
At least it’s given you something to write about neon, I’ve never known anyone so miserable and sad, you really need to get a woman
Destiny will have the same destiny like STX, POLX, AVCT, FAB, LLAI, OBD etc. It was virtually pumped by every podcasters, innocent investors believed the hype, invested hard earned cash and now counting losses after losses. I was one of them and learned my lessons the hardest way possible.
Wgumcd
You made reference to Steriwave being 50% effective, but the following extract from Edison states:
"In Q422, the company reported that its US Phase II nasal disinfection study met the primary endpoint of eliminating or significantly decreasing nasal Staphylococcus aureus in 86% of carriers. "
Here is the link to the article: https://www.edisongroup.com/research/steriwave-initiates-uk-pilot-study-with-nhs/32588/
Ffs give us simple shareholders a heads up
No comment from my resident friend Brooko.....sure it will come.....wonder whether he still thinks 80p was a good buy in price😊☘️